Literature DB >> 26801561

TIEG1 enhances Osterix expression and mediates its induction by TGFβ and BMP2 in osteoblasts.

Malayannan Subramaniam1, Kevin S Pitel1, Sarah G Withers1, Hicham Drissi2, John R Hawse3.   

Abstract

Deletion of TIEG1/KLF10 in mice results in an osteopenic skeletal phenotype with significant decreases in both bone mineral density and content throughout the skeleton. Calvarial osteoblasts isolated from TIEG1 knockout (KO) mice display numerous changes in gene expression and exhibit significant delays in their mineralization rates relative to wild-type (WT) controls. Here, we demonstrate that loss of TIEG1 expression in osteoblasts results in decreased levels of Osterix mRNA. Suppression of TIEG1 expression in WT osteoblasts leads to decreased Osterix expression while restoration of TIEG1 expression in TIEG1 KO osteoblasts results in increased levels of Osterix. Transient transfection and chromatin immunoprecipitation assays reveal that TIEG1 directly binds to and activates the Osterix promoter and demonstrate that the zinc finger-containing DNA binding domain of TIEG1 is necessary for this regulation. Furthermore, we reveal that TIEG1 expression is essential for the induction of Osterix expression by important bone-related cytokines such as TGFβ and BMP2 in osteoblast cells. Taken together, these data implicate an important role for TIEG1 in regulating the expression of Osterix, a master regulator of osteoblast differentiation and bone formation, and suggest that decreased expression of Osterix, as well as impaired TGFβ and BMP2 signaling, contribute to the observed osteopenic bone phenotype of TIEG1 KO mice.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMP2; KLF10; Osteoblast; Osterix; TGFβ; TIEG1

Mesh:

Substances:

Year:  2016        PMID: 26801561      PMCID: PMC4747784          DOI: 10.1016/j.bbrc.2016.01.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  The leukocyte integrin gene CD11d is repressed by gut-enriched Kruppel-like factor 4 in myeloid cells.

Authors:  John D Noti; Andrew K Johnson; Jill D Dillon
Journal:  J Biol Chem       Date:  2004-11-23       Impact factor: 5.157

2.  TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro.

Authors:  Malayannan Subramaniam; Genevieve Gorny; Steven A Johnsen; David G Monroe; Glenda L Evans; Daniel G Fraser; David J Rickard; Kay Rasmussen; Jan M A van Deursen; Russell T Turner; Merry Jo Oursler; Thomas C Spelsberg
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 3.  Transcriptional control of osteoblast growth and differentiation.

Authors:  G S Stein; J B Lian; J L Stein; A J Van Wijnen; M Montecino
Journal:  Physiol Rev       Date:  1996-04       Impact factor: 37.312

4.  The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.

Authors:  Kazuhisa Nakashima; Xin Zhou; Gary Kunkel; Zhaoping Zhang; Jian Min Deng; Richard R Behringer; Benoit de Crombrugghe
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

5.  A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction.

Authors:  K Miyama; G Yamada; T S Yamamoto; C Takagi; K Miyado; M Sakai; N Ueno; H Shibuya
Journal:  Dev Biol       Date:  1999-04-01       Impact factor: 3.582

6.  Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.

Authors:  Steven A Johnsen; Malayannan Subramaniam; Takenobu Katagiri; Ralf Janknecht; Thomas C Spelsberg
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

7.  TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses.

Authors:  Steven A Johnsen; Malayannan Subramaniam; Ralf Janknecht; Thomas C Spelsberg
Journal:  Oncogene       Date:  2002-08-22       Impact factor: 9.867

8.  Modulation of transforming growth factor beta (TGFbeta)/Smad transcriptional responses through targeted degradation of TGFbeta-inducible early gene-1 by human seven in absentia homologue.

Authors:  Steven A Johnsen; Malayannan Subramaniam; David G Monroe; Ralf Janknecht; Thomas C Spelsberg
Journal:  J Biol Chem       Date:  2002-06-18       Impact factor: 5.157

9.  BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression.

Authors:  Mi-Hye Lee; Youn-Jeong Kim; Hyun-Jung Kim; Hyun-Dong Park; Ae-Ree Kang; Hee-Moon Kyung; Jae-Hyun Sung; John M Wozney; Hyun-Jung Kim; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2003-06-18       Impact factor: 5.157

10.  Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts.

Authors:  M Subramaniam; S A Harris; M J Oursler; K Rasmussen; B L Riggs; T C Spelsberg
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

View more
  8 in total

1.  TIEG and estrogen modulate SOST expression in the murine skeleton.

Authors:  Malayannan Subramaniam; Kevin S Pitel; Elizabeth S Bruinsma; David G Monroe; John R Hawse
Journal:  J Cell Physiol       Date:  2017-11-24       Impact factor: 6.384

2.  Sclerostin antibody treatment rescues the osteopenic bone phenotype of TGFβ inducible early gene-1 knockout female mice.

Authors:  Anne Gingery; Malayannan Subramaniam; Kevin S Pitel; Xiaodong Li; Hua Z Ke; Russell T Turner; Urszula T Iwaniec; John R Hawse
Journal:  J Cell Physiol       Date:  2020-01-24       Impact factor: 6.384

3.  Retinoblastoma cell-derived Twist protein promotes regulatory T cell development.

Authors:  Ruishi Zhang; Yan-Nan Song; Xiaoyan Duo; Zhihong Guo; Yanhua Sun; Zhixiong Zhang; Yongtian Lu; Beiping Miao; Ping-Chang Yang; Guohui Nie
Journal:  Cancer Immunol Immunother       Date:  2020-10-27       Impact factor: 6.968

4.  TIEG1 modulates β-catenin sub-cellular localization and enhances Wnt signaling in bone.

Authors:  Malayannan Subramaniam; Muzaffer Cicek; Kevin S Pitel; Elizabeth S Bruinsma; Molly H Nelson Holte; Sarah G Withers; Nalini M Rajamannan; Frank J Secreto; K Venuprasad; John R Hawse
Journal:  Nucleic Acids Res       Date:  2017-05-19       Impact factor: 16.971

5.  TIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathway.

Authors:  Mingqiu Cen; Pengfei Hu; Zhaobin Cai; Tianfu Fang; Jiancheng Zhang; Ming Lu
Journal:  Int J Mol Med       Date:  2017-02-13       Impact factor: 4.101

6.  Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica.

Authors:  Wing Lee Chan; Magdalena Steiner; Tomasz Witkos; Johannes Egerer; Björn Busse; Shuji Mizumoto; Jan M Pestka; Haikuo Zhang; Ingrid Hausser; Layal Abo Khayal; Claus-Eric Ott; Mateusz Kolanczyk; Bettina Willie; Thorsten Schinke; Chiara Paganini; Antonio Rossi; Kazuyuki Sugahara; Michael Amling; Petra Knaus; Danny Chan; Martin Lowe; Stefan Mundlos; Uwe Kornak
Journal:  PLoS Genet       Date:  2018-03-21       Impact factor: 5.917

7.  Neuromodulation of bone: Role of different peptides and their interactions (Review).

Authors:  Xiaoyu Wang; Jia Xu; Qinglin Kang
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

Review 8.  Recent Advances of Osterix Transcription Factor in Osteoblast Differentiation and Bone Formation.

Authors:  Qian Liu; Mao Li; Shiyi Wang; Zhousheng Xiao; Yuanyuan Xiong; Guangwei Wang
Journal:  Front Cell Dev Biol       Date:  2020-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.